Myriad Genetics Inc. (MYGN)

[surf1944]

7:08AM Myriad Genetics Study Highlights Importance of myRisk Hereditary Cancer Testing; Data to be Presented at the National Society of Genetic Counselors Annual Meeting (MYGN) 24.25 : Co announces it will present data showing the high prevalence and overlap between hereditary colon cancer and hereditary breast and ovarian cancer in patients previously diagnosed with endometrial and ovarian cancer. The presentations will take place Oct 11.

Prevalence of Lynch Syndrome and HBOC among Patients with Primary Endometrial and Primary Ovarian Cancers
Results showed that among 1,529 patients evaluated 11.2% had a deleterious mutation with 73.3% of the mutations in hereditary colon cancer genes and 26.7% in hereditary breast cancer genes. Although the prevalence of hereditary colon cancer was higher than hereditary breast cancer in patients with endometrial and ovarian cancers, these patients showed a strong family history overlap between the two syndromes. The findings suggest these patients would be appropriate candidates for testing with a hereditary cancer panel to prevent a missed diagnosis of hereditary cancer.